IBDEI0Q7 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11773,1,4,0)
;;=4^N06.8
;;^UTILITY(U,$J,358.3,11773,2)
;;=^5015557
;;^UTILITY(U,$J,358.3,11774,0)
;;=N06.9^^46^573^41
;;^UTILITY(U,$J,358.3,11774,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11774,1,3,0)
;;=3^Isolated proteinuria w/ unspecified morphologic lesion
;;^UTILITY(U,$J,358.3,11774,1,4,0)
;;=4^N06.9
;;^UTILITY(U,$J,358.3,11774,2)
;;=^5015558
;;^UTILITY(U,$J,358.3,11775,0)
;;=N07.0^^46^573^29
;;^UTILITY(U,$J,358.3,11775,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11775,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ minor glomerular abnormality
;;^UTILITY(U,$J,358.3,11775,1,4,0)
;;=4^N07.0
;;^UTILITY(U,$J,358.3,11775,2)
;;=^5015559
;;^UTILITY(U,$J,358.3,11776,0)
;;=N07.1^^46^573^28
;;^UTILITY(U,$J,358.3,11776,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11776,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ focal & seg glomerular lesions
;;^UTILITY(U,$J,358.3,11776,1,4,0)
;;=4^N07.1
;;^UTILITY(U,$J,358.3,11776,2)
;;=^5015560
;;^UTILITY(U,$J,358.3,11777,0)
;;=N07.2^^46^573^24
;;^UTILITY(U,$J,358.3,11777,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11777,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ diffuse membranous glomrlneph
;;^UTILITY(U,$J,358.3,11777,1,4,0)
;;=4^N07.2
;;^UTILITY(U,$J,358.3,11777,2)
;;=^5015561
;;^UTILITY(U,$J,358.3,11778,0)
;;=N07.3^^46^573^25
;;^UTILITY(U,$J,358.3,11778,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11778,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ diffuse mesangial prolif glomrlneph
;;^UTILITY(U,$J,358.3,11778,1,4,0)
;;=4^N07.3
;;^UTILITY(U,$J,358.3,11778,2)
;;=^5015562
;;^UTILITY(U,$J,358.3,11779,0)
;;=N07.4^^46^573^23
;;^UTILITY(U,$J,358.3,11779,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11779,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ diffus endocaplry prolif glomrlneph
;;^UTILITY(U,$J,358.3,11779,1,4,0)
;;=4^N07.4
;;^UTILITY(U,$J,358.3,11779,2)
;;=^5015563
;;^UTILITY(U,$J,358.3,11780,0)
;;=N07.5^^46^573^26
;;^UTILITY(U,$J,358.3,11780,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11780,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ diffuse mesangiocap glomrlneph
;;^UTILITY(U,$J,358.3,11780,1,4,0)
;;=4^N07.5
;;^UTILITY(U,$J,358.3,11780,2)
;;=^5015564
;;^UTILITY(U,$J,358.3,11781,0)
;;=N07.6^^46^573^22
;;^UTILITY(U,$J,358.3,11781,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11781,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ dense deposit disease
;;^UTILITY(U,$J,358.3,11781,1,4,0)
;;=4^N07.6
;;^UTILITY(U,$J,358.3,11781,2)
;;=^5015565
;;^UTILITY(U,$J,358.3,11782,0)
;;=N07.7^^46^573^27
;;^UTILITY(U,$J,358.3,11782,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11782,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ diffuse crescentic glomrlneph
;;^UTILITY(U,$J,358.3,11782,1,4,0)
;;=4^N07.7
;;^UTILITY(U,$J,358.3,11782,2)
;;=^5015566
;;^UTILITY(U,$J,358.3,11783,0)
;;=N07.8^^46^573^30
;;^UTILITY(U,$J,358.3,11783,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11783,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ oth morphologic lesions
;;^UTILITY(U,$J,358.3,11783,1,4,0)
;;=4^N07.8
;;^UTILITY(U,$J,358.3,11783,2)
;;=^5015567
;;^UTILITY(U,$J,358.3,11784,0)
;;=N07.9^^46^573^31
;;^UTILITY(U,$J,358.3,11784,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11784,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ unsp morphologic lesions
;;^UTILITY(U,$J,358.3,11784,1,4,0)
;;=4^N07.9
;;^UTILITY(U,$J,358.3,11784,2)
;;=^5015568
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0Q7 3762 printed Apr 09, 2024@21:44:18 Page 2
IBDEI0Q7 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11773,1,4,0)
+2 ;;=4^N06.8
+3 ;;^UTILITY(U,$J,358.3,11773,2)
+4 ;;=^5015557
+5 ;;^UTILITY(U,$J,358.3,11774,0)
+6 ;;=N06.9^^46^573^41
+7 ;;^UTILITY(U,$J,358.3,11774,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,11774,1,3,0)
+10 ;;=3^Isolated proteinuria w/ unspecified morphologic lesion
+11 ;;^UTILITY(U,$J,358.3,11774,1,4,0)
+12 ;;=4^N06.9
+13 ;;^UTILITY(U,$J,358.3,11774,2)
+14 ;;=^5015558
+15 ;;^UTILITY(U,$J,358.3,11775,0)
+16 ;;=N07.0^^46^573^29
+17 ;;^UTILITY(U,$J,358.3,11775,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,11775,1,3,0)
+20 ;;=3^Hereditary nephropathy, NEC w/ minor glomerular abnormality
+21 ;;^UTILITY(U,$J,358.3,11775,1,4,0)
+22 ;;=4^N07.0
+23 ;;^UTILITY(U,$J,358.3,11775,2)
+24 ;;=^5015559
+25 ;;^UTILITY(U,$J,358.3,11776,0)
+26 ;;=N07.1^^46^573^28
+27 ;;^UTILITY(U,$J,358.3,11776,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,11776,1,3,0)
+30 ;;=3^Hereditary nephropathy, NEC w/ focal & seg glomerular lesions
+31 ;;^UTILITY(U,$J,358.3,11776,1,4,0)
+32 ;;=4^N07.1
+33 ;;^UTILITY(U,$J,358.3,11776,2)
+34 ;;=^5015560
+35 ;;^UTILITY(U,$J,358.3,11777,0)
+36 ;;=N07.2^^46^573^24
+37 ;;^UTILITY(U,$J,358.3,11777,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,11777,1,3,0)
+40 ;;=3^Hereditary nephropathy, NEC w/ diffuse membranous glomrlneph
+41 ;;^UTILITY(U,$J,358.3,11777,1,4,0)
+42 ;;=4^N07.2
+43 ;;^UTILITY(U,$J,358.3,11777,2)
+44 ;;=^5015561
+45 ;;^UTILITY(U,$J,358.3,11778,0)
+46 ;;=N07.3^^46^573^25
+47 ;;^UTILITY(U,$J,358.3,11778,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,11778,1,3,0)
+50 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangial prolif glomrlneph
+51 ;;^UTILITY(U,$J,358.3,11778,1,4,0)
+52 ;;=4^N07.3
+53 ;;^UTILITY(U,$J,358.3,11778,2)
+54 ;;=^5015562
+55 ;;^UTILITY(U,$J,358.3,11779,0)
+56 ;;=N07.4^^46^573^23
+57 ;;^UTILITY(U,$J,358.3,11779,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,11779,1,3,0)
+60 ;;=3^Hereditary nephropathy, NEC w/ diffus endocaplry prolif glomrlneph
+61 ;;^UTILITY(U,$J,358.3,11779,1,4,0)
+62 ;;=4^N07.4
+63 ;;^UTILITY(U,$J,358.3,11779,2)
+64 ;;=^5015563
+65 ;;^UTILITY(U,$J,358.3,11780,0)
+66 ;;=N07.5^^46^573^26
+67 ;;^UTILITY(U,$J,358.3,11780,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,11780,1,3,0)
+70 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangiocap glomrlneph
+71 ;;^UTILITY(U,$J,358.3,11780,1,4,0)
+72 ;;=4^N07.5
+73 ;;^UTILITY(U,$J,358.3,11780,2)
+74 ;;=^5015564
+75 ;;^UTILITY(U,$J,358.3,11781,0)
+76 ;;=N07.6^^46^573^22
+77 ;;^UTILITY(U,$J,358.3,11781,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,11781,1,3,0)
+80 ;;=3^Hereditary nephropathy, NEC w/ dense deposit disease
+81 ;;^UTILITY(U,$J,358.3,11781,1,4,0)
+82 ;;=4^N07.6
+83 ;;^UTILITY(U,$J,358.3,11781,2)
+84 ;;=^5015565
+85 ;;^UTILITY(U,$J,358.3,11782,0)
+86 ;;=N07.7^^46^573^27
+87 ;;^UTILITY(U,$J,358.3,11782,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,11782,1,3,0)
+90 ;;=3^Hereditary nephropathy, NEC w/ diffuse crescentic glomrlneph
+91 ;;^UTILITY(U,$J,358.3,11782,1,4,0)
+92 ;;=4^N07.7
+93 ;;^UTILITY(U,$J,358.3,11782,2)
+94 ;;=^5015566
+95 ;;^UTILITY(U,$J,358.3,11783,0)
+96 ;;=N07.8^^46^573^30
+97 ;;^UTILITY(U,$J,358.3,11783,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,11783,1,3,0)
+100 ;;=3^Hereditary nephropathy, NEC w/ oth morphologic lesions
+101 ;;^UTILITY(U,$J,358.3,11783,1,4,0)
+102 ;;=4^N07.8
+103 ;;^UTILITY(U,$J,358.3,11783,2)
+104 ;;=^5015567
+105 ;;^UTILITY(U,$J,358.3,11784,0)
+106 ;;=N07.9^^46^573^31
+107 ;;^UTILITY(U,$J,358.3,11784,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,11784,1,3,0)
+110 ;;=3^Hereditary nephropathy, NEC w/ unsp morphologic lesions
+111 ;;^UTILITY(U,$J,358.3,11784,1,4,0)
+112 ;;=4^N07.9
+113 ;;^UTILITY(U,$J,358.3,11784,2)
+114 ;;=^5015568
